Applied DNA Sciences (NASDAQ:APDN) reported its Q4 earnings results on Thursday, December 9, 2021 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Applied DNA Sciences missed estimated earnings by 62.16%, reporting an EPS of $-0.6 versus an estimate of $-0.37, which surprised analysts.
Revenue was up $2,686,000.00 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.24, which was followed by a 3.06% drop in the share price the next day.
Here’s a look at Applied DNA Sciences’s past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.22 | -0.21 | -0.54 | -0.52 |
| EPS Actual | -0.46 | -0.33 | -0.56 | -0.82 |
| Revenue Estimate | 3.13M | 2.60M | 1.36M | 710.00K |
| Revenue Actual | 1.70M | 2.67M | 1.62M | 314.00K |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
